Andreas Kerschbaumer
机构：Senatsverwaltung für Stadtentwicklung und Wohnen, Stanford Medicine, Medical University of Vienna, Stanford University · ORCID：0000-0002-6685-8873
发表论文 166 篇 · 总被引 10479 次 · h-index 38
代表论文
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update (2026 · Annals of the Rheumatic Diseases · 被引 48)
- Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update (2025 · Annals of the Rheumatic Diseases · 被引 37)
- Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases – a systematic literature review informing the 2024 update of an international expert consensus statement (2025 · Annals of the Rheumatic Diseases · 被引 20)
- Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases a systematic literature review informing the 2024 update of an international consensus statement (2025 · Annals of the Rheumatic Diseases · 被引 17)
- Global Recruiting Patterns and Placebo Response Rates in Clinical Trials of Psoriatic Arthritis and Plaque Psoriasis (2025 · Arthritis & Rheumatology · 被引 15)
- Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024 (2025 · Annals of the Rheumatic Diseases · 被引 7)